- Home
- SIMO vs BEAM Comparison
SIMO vs BEAM Comparison
Compare SIMO & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIMO
- BEAM
- Stock Information
- Founded
- SIMO 1995
- BEAM 2017
- Country
- SIMO Hong Kong
- BEAM United States
- Employees
- SIMO N/A
- BEAM N/A
- Industry
- SIMO Semiconductors
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIMO Technology
- BEAM Health Care
- Exchange
- SIMO Nasdaq
- BEAM Nasdaq
- Market Cap
- SIMO 2.4B
- BEAM 1.6B
- IPO Year
- SIMO 2005
- BEAM 2020
- Fundamental
- Price
- SIMO $74.81
- BEAM $20.01
- Analyst Decision
- SIMO Strong Buy
- BEAM Strong Buy
- Analyst Count
- SIMO 8
- BEAM 11
- Target Price
- SIMO $80.63
- BEAM $48.90
- AVG Volume (30 Days)
- SIMO 342.8K
- BEAM 2.0M
- Earning Date
- SIMO 07-31-2025
- BEAM 08-05-2025
- Dividend Yield
- SIMO 2.67%
- BEAM N/A
- EPS Growth
- SIMO 59.19
- BEAM N/A
- EPS
- SIMO 2.80
- BEAM N/A
- Revenue
- SIMO $780,733,000.00
- BEAM $63,578,000.00
- Revenue This Year
- SIMO $2.23
- BEAM N/A
- Revenue Next Year
- SIMO $13.23
- BEAM $8.82
- P/E Ratio
- SIMO $26.75
- BEAM N/A
- Revenue Growth
- SIMO 10.84
- BEAM N/A
- 52 Week Low
- SIMO $37.21
- BEAM $13.53
- 52 Week High
- SIMO $85.00
- BEAM $35.25
- Technical
- Relative Strength Index (RSI)
- SIMO 69.69
- BEAM 68.31
- Support Level
- SIMO $73.09
- BEAM $16.59
- Resistance Level
- SIMO $76.77
- BEAM $17.38
- Average True Range (ATR)
- SIMO 2.11
- BEAM 1.10
- MACD
- SIMO -0.02
- BEAM 0.35
- Stochastic Oscillator
- SIMO 81.68
- BEAM 89.70
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.